BenQ Medical Technology (4116) — Free Cash Flow Generation Index

Latest as of June 2025: 0.92x

BenQ Medical Technology (4116) has a Free Cash Flow Generation Index of 0.92x as of June 2025. Free cash flow of NT$164.28 Million represents 1% of operating cash flow (NT$179.07 Million). See BenQ Medical Technology current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

0.92x
Free Cash Flow / Operating CF

Free Cash Flow

NT$164.28 Million
TWD

Operating Cash Flow

NT$179.07 Million
TWD

Capital Expenditures

NT$14.79 Million
TWD

BenQ Medical Technology Free Cash Flow Generation Index (2017–2024)

Historical FCF Generation Index trend for BenQ Medical Technology across 8 annual periods. Explore BenQ Medical Technology (4116) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for BenQ Medical Technology (2017–2024)

Year-by-year Free Cash Flow Generation Index for BenQ Medical Technology. For the full company profile including market capitalisation, see BenQ Medical Technology market capitalisation.

Year FCG Index Free Cash Flow (TWD) Operating CF Capital Expenditures YoY Change
2024 0.21x NT$46.74 Million NT$222.22 Million NT$175.48 Million ▼ -69.3%
2023 0.69x NT$303.07 Million NT$442.35 Million NT$139.28 Million ▼ -18.6%
2022 0.84x NT$318.72 Million NT$378.77 Million NT$60.05 Million ▲ +15.5%
2021 0.73x NT$88.42 Million NT$121.35 Million NT$32.92 Million ▲ +1.2%
2020 0.72x NT$109.12 Million NT$151.48 Million NT$42.37 Million ▼ -17.7%
2019 0.88x NT$148.09 Million NT$169.23 Million NT$21.15 Million ▲ +25.9%
2018 0.70x NT$87.67 Million NT$126.10 Million NT$31.36 Million ▲ +223.0%
2017 -0.57x NT$-41.26 Million NT$72.97 Million NT$112.31 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).